Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique

Table 2 Characteristics of patients with virological failure (HIV-RNA >400 copies/mL) and nevirapine plasma concentrations below 3 mg/L

Patient ID	sex	Age (years)	Nevirapine plasma conc. (mg/L)	30-day adherence	Viral load (copies/mL)	NNRTI DRMs	NRTI DRMs
MBA029	female	30	0.44	100%	40768	K103N	M184IMV
JCR089	female	32	0.21	95- < 100%	966	ND	ND
JCR086	male	48	0.03	100%	696298	G190A	None

NNRTI = non-nucleoside reverse transcriptase inhibitor, NRTI = nucleoside reverse transcriptase inhibitor, DRM = drug resistance mutation (as identified Stanford Genotypic Resistance Interpretation Algorithm), ND = no data available.

ISSN: 1471-2334